Afuco™ Anti-MUC1 ADCC Therapeutic Antibody (Cantuzumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to MUC1. Cantuzumab mertansine is a humanized monoclonal antibody used to treat colorectal cancer and other types of cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-166 |
| Pricing | Inquiry |
| Host | Human |
| Target | MUC1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | IP, IF, FuncS, FC, Neut, ELISA |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |